Celling SpineSmith and Systems team up to research adipose tissue derived stem cell applications Celling Systems, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc köpa xenical . To research potential applications for adipose tissue derived adult stem cells. SpineSmith acquired the global rights in spine for Cells Genesis’ adipose cells derived stem cell technology in November of 2007. Replacing the last arrangement, this new unique agreement allows Celling Systems to further research adipose cells derived stem cells in a variety of human applications, including orthopedics, vascular, trauma, plastics and disease, in certain agreed upon medical institutes.
Hixon Seat in Investigative Medicine. ‘We are honored that the National Eyes Institute is assisting this essential research.’.. Cedars-Sinai receives National Attention Institute grant to develop gene therapy for corneal disease Cedars-Sinai stem cell researchers investigating methods to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Attention Institute to develop gene therapy in corneal stem cells to ease damage to corneas that may cause vision loss. ‘Diabetes may be the leading reason behind blindness among working-age group adults,’ stated Alexander V. Ljubimov, PhD, director of the Ophthalmology Research Laboratories at the Cedars-Sinai Regenerative Medication Institute and principal investigator on the five-calendar year grant.